HomeAI · summaries
Storia in 2 fonti
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation - The Economic Times
Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year,…
- ·
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma
Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements…
- ·
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition…
- ·
thehindubusinessline.com
Honasa Consumer to acquire 58% stake in Fluence Pharma
In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches…
- ·
Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma
Honasa shares drop 3% after announcing acquisition of Fluence Pharma, despite initial gains and positive long-term market outlook.